EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Mixed Long Term Returns
Jupiter Asset Management Ltd. Sells 779,802 Shares of Novavax, Inc. $NVAX
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Brokerages
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Novavax (NASDAQ:NVAX) Stock Passes Above 200 Day Moving Average - Time to Sell? - Daily Political
Novavax (NASDAQ:NVAX) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?
Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Partnership Shifts
Novavax (NVAX) Is Up 5.5% After Easing Inflation Boosts Interest In Protein-Based Vaccines
Pfizer Reshapes Portfolio With Metsera Deal Novavax Pact And R&D Push - Simply Wall St News
Novavax (NASDAQ:NVAX) Downgraded to "Sell" Rating by Wall Street Zen - Markets Daily
Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
